Liver Cancer
📧 Sign up to get email alerts when something new happens for Liver Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-01-01Clinical Trial Update: A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors [Phase 2]
A Phase 2 pilot study evaluating Thermodox in combination with MR-HIFU for relapsed solid tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-29Clinical Trial Update: Treat-and-resect Study of Echo Decorrelation Imaging-controlled Radiofrequency Ablation in Liver Tumors [NA]
The treat-and-resect study of Echo Decorrelation Imaging–controlled Radiofrequency Ablation for liver tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-13Clinical Trial Update: GI Organ Tracking Via Balloon Applicators [NA]
A clinical trial evaluating GI organ tracking via balloon applicators sponsored by Washington University School of Medicine has been withdra…
-
CLINICAL_TRIALS withdrawal · 2022-04-01Clinical Trial Update: Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases [Phase 2, Phase 3]
A study evaluating anti-CEA CAR-T plus chemotherapy versus chemotherapy alone in pancreatic cancer with liver metastases has been withdrawn …
-
CLINICAL_TRIALS withdrawal · 2021-01-27Clinical Trial Update: Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium [Phase 4]
Phase 4 trial for improving CBCT imaging with gadoxetate disodium in liver SBRT has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-05-17Clinical Trial Update: Evaluation of Intrafractional Motion of Liver Tumors Using Markers [NA]
Clinical trial NCT02095236 evaluating intrafractional motion of liver tumors using markers has been withdrawn from the registry.
-
CLINICAL_TRIALS withdrawal · 2018-04-09Clinical Trial Update: Early Palliative Care Integration in Interventional Cancer Care [NA]
University of Miami-sponsored trial (NCT03185416) evaluating early palliative care integration in interventional cancer care has been withdr…
-
CLINICAL_TRIALS withdrawal · 2017-03-03Clinical Trial Update: Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases [Phase 4]
A Phase 4 clinical trial comparing radiofrequency ablation plus chemotherapy versus chemotherapy alone for patients with secondary liver can…
-
CLINICAL_TRIALS withdrawal · 2014-09-09Clinical Trial Update: Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery [Phase 2]
A Phase 2 study of selumetinib combined with MK-2206 for refractory or advanced gallbladder and biliary tract cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-07-22Clinical Trial Update: Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease [Phase 1]
A Phase 1 trial of TheraSphere in combination with Everolimus for neuroendocrine tumors with liver-dominant disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-10Clinical Trial Update: Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
A clinical trial investigating biomarkers in stored tumor samples from younger patients with liver cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-09-17Clinical Trial Update: Celecoxib and Erlotinib in Treating Patients With Liver Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating the combination of celecoxib and erlotinib for liver cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-04-18Clinical Trial Update: Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or Transplant [Phase 2]
A Phase 2 trial evaluating stereotactic body radiation therapy for unresectable primary liver cancers, including hepatocellular carcinoma, h…